Erol Wiegert
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
- Oncology 6
- CAR-T cell therapy research 6
-
- Ubiquitin and proteasome pathways 1
- Co-authors
- Viktoria Moschetti (1 shared paper)Harm Peters (1 shared paper)Karl‐Heinz Liesenfeld (1 shared paper)Andreas Clemens (1 shared paper)Dmytro Khadzhynov (1 shared paper)Sebastian Härtter (1 shared paper)Thorsten Lehr (1 shared paper)Stephan Formella (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Neuro-Oncology (1 paper)Annals of Oncology (1 paper)Journal of Hypertension (1 paper)Clinical and Experimental Hypertension (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Erol Wiegert
13 papers receiving 272 citations
Peers
Comparison fields: 5 of 46
- Internal Medicine 89
- Cardiology and Cardiovascular Medicine 148
- Physiology 10
- Oncology 47
- Immunology 30
Countries citing papers authored by Erol Wiegert
This map shows the geographic impact of Erol Wiegert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erol Wiegert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erol Wiegert more than expected).
Fields of papers citing papers by Erol Wiegert
This network shows the impact of papers produced by Erol Wiegert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erol Wiegert. The network helps show where Erol Wiegert may publish in the future.
Co-authors
The 25 scholars most cited alongside Erol Wiegert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 160 | |
| 2 | 2011 | 22 | |
| 3 | 2022 | 16 | |
| 4 | 2021 | 15 | |
| 5 | 2021 | 15 | |
| 6 | 2020 | 12 | |
| 7 | 2012 | 11 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 7 | |
| 10 | 2023 | 6 | |
| 11 | 2020 | 2 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 1 | |
| 14 | 2024 | 0 |
About Erol Wiegert
Erol Wiegert is a scholar working on Oncology, Molecular Biology, Genetics, Biotechnology and Immunology, having authored 14 papers that have together received 276 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Virus-based gene therapy research (4 papers), Cancer Research and Treatments (3 papers), Biosimilars and Bioanalytical Methods (2 papers), Click Chemistry and Applications (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Ubiquitin and proteasome pathways (1 paper) and Sodium Intake and Health (1 paper). The work is most often cited by research in Internal Medicine (89 citations), Cardiology and Cardiovascular Medicine (148 citations), Physiology (10 citations), Oncology (47 citations) and Immunology (30 citations). Erol Wiegert has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Viktoria Moschetti, Harm Peters, Karl‐Heinz Liesenfeld, Andreas Clemens, Dmytro Khadzhynov, Sebastian Härtter, Thorsten Lehr, Stephan Formella, Hans‐H. Neumayer and Frank Wagner. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Annals of Oncology, Journal of Hypertension and Clinical and Experimental Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.